BRAF and melanoma: Using a proteomic approach, it has been shown that even short-term exposure to BRAF inhibitors leads to an early state of cellular adaptation and differentiation; inhibition of the MAPK pathway results in the “proliferation” of melanoma cells, harboring at least partially the phenotypic characteristics of the “invasive” state.